The extreme weather events we’ve all been watching are reminders of the myriad implications of climate change for human health, food security, the economy, geopolitics, biodiversity, and how we live each day. They demand an all-hands-on-deck approach to reducing the causes of global warming. Let’s focus here on the hospital and pharmaceutical sectors.

The Anglo-Swedish drugmaker said the long-term agreement with Massachusetts-based Vanguard Renewables would enable it to transition to biogas from natural gas and cut its emissions across its U.S. research and manufacturing sites.

Much of the global pharmaceutical and biotech industry has yet to set any targets for reducing carbon emissions in line with the Paris Agreement, a new analysis has found, despite the biggest companies in the sector leading the way.